Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 275

1.

Efficacy and safety of alemtuzumab in a real-life cohort of patients with multiple sclerosis.

Frau J, Coghe G, Lorefice L, Fenu G, Musu L, Cocco E.

J Neurol. 2019 Mar 12. doi: 10.1007/s00415-019-09272-6. [Epub ahead of print]

PMID:
30863891
2.

Assessing the Metabolomic Profile of Multiple Sclerosis Patients Treated with Interferon Beta 1a by 1H-NMR Spectroscopy.

Lorefice L, Murgia F, Fenu G, Frau J, Coghe G, Murru MR, Tranquilli S, Visconti A, Marrosu MG, Atzori L, Cocco E.

Neurotherapeutics. 2019 Feb 28. doi: 10.1007/s13311-019-00721-8. [Epub ahead of print]

PMID:
30820880
3.

Human Ovarian Cancer Tumor Formation in Severe Combined Immunodeficient (SCID) Pigs.

Boettcher AN, Kiupel M, Adur MK, Cocco E, Santin AD, Bellone S, Charley SE, Blanco-Fernandez B, Risinger JI, Ross JW, Tuggle CK, Shapiro EM.

Front Oncol. 2019 Jan 22;9:9. doi: 10.3389/fonc.2019.00009. eCollection 2019.

4.

Factors interfering with parenthood decision-making in an Italian sample of people with multiple sclerosis: an exploratory online survey.

Lavorgna L, Esposito S, Lanzillo R, Sparaco M, Ippolito D, Cocco E, Fenu G, Borriello G, De Mercanti S, Frau J, Capuano R, Trojsi F, Rosa L, Clerico M, Laroni A, Morra VB, Tedeschi G, Bonavita S.

J Neurol. 2019 Mar;266(3):707-716. doi: 10.1007/s00415-019-09193-4. Epub 2019 Jan 16.

PMID:
30649617
5.

Colorectal Carcinomas Containing Hypermethylated MLH1 Promoter and Wild-Type BRAF/KRAS Are Enriched for Targetable Kinase Fusions.

Cocco E, Benhamida J, Middha S, Zehir A, Mullaney K, Shia J, Yaeger R, Zhang L, Wong D, Villafania L, Nafa K, Scaltriti M, Drilon A, Saltz L, Schram AM, Stadler ZK, Hyman DM, Benayed R, Ladanyi M, Hechtman JF.

Cancer Res. 2019 Mar 15;79(6):1047-1053. doi: 10.1158/0008-5472.CAN-18-3126. Epub 2019 Jan 14.

PMID:
30643016
6.

PI3K oncogenic mutations mediate resistance to afatinib in HER2/neu overexpressing gynecological cancers.

Bonazzoli E, Cocco E, Lopez S, Bellone S, Zammataro L, Bianchi A, Manzano A, Yadav G, Manara P, Perrone E, Haines K, Espinal M, Dugan K, Menderes G, Altwerger G, Han C, Zeybek B, Litkouhi B, Ratner E, Silasi DA, Huang GS, Azodi M, Schwartz PE, Santin AD.

Gynecol Oncol. 2019 Jan 7. pii: S0090-8258(19)30004-6. doi: 10.1016/j.ygyno.2019.01.002. [Epub ahead of print]

PMID:
30630630
7.

Performance in daily activities, cognitive impairment and perception in multiple sclerosis patients and their caregivers.

Fenu G, Fronza M, Lorefice L, Arru M, Coghe G, Frau J, Marrosu MG, Cocco E.

BMC Neurol. 2018 Dec 19;18(1):212. doi: 10.1186/s12883-018-1224-z.

8.

Assessing the burden of vascular risk factors on brain atrophy in multiple sclerosis: A case- control MRI study.

Lorefice L, Frau J, Coghe G, Pitzalis R, Gessa I, Contu F, Barracciu MA, Marrosu MG, Cocco E, Fenu G.

Mult Scler Relat Disord. 2019 Jan;27:74-78. doi: 10.1016/j.msard.2018.10.011. Epub 2018 Oct 16.

PMID:
30343253
9.

Quantifying gait impairment in individuals affected by Charcot-Marie-Tooth disease: the usefulness of gait profile score and gait variable score.

Coghe G, Pau M, Mamusa E, Pisano C, Corona F, Pilloni G, Porta M, Marrosu G, Vannelli A, Frau J, Lorefice L, Fenu G, Marrosu MG, Cocco E.

Disabil Rehabil. 2018 Oct 18:1-6. doi: 10.1080/09638288.2018.1506946. [Epub ahead of print]

PMID:
30334469
10.

NTRK fusion-positive cancers and TRK inhibitor therapy.

Cocco E, Scaltriti M, Drilon A.

Nat Rev Clin Oncol. 2018 Dec;15(12):731-747. doi: 10.1038/s41571-018-0113-0. Review.

PMID:
30333516
11.

Neratinib is effective in breast tumors bearing both amplification and mutation of ERBB2 (HER2).

Cocco E, Javier Carmona F, Razavi P, Won HH, Cai Y, Rossi V, Chan C, Cownie J, Soong J, Toska E, Shifman SG, Sarotto I, Savas P, Wick MJ, Papadopoulos KP, Moriarty A, Cutler RE Jr, Avogadri-Connors F, Lalani AS, Bryce RP, Chandarlapaty S, Hyman DM, Solit DB, Boni V, Loi S, Baselga J, Berger MF, Montemurro F, Scaltriti M.

Sci Signal. 2018 Oct 9;11(551). pii: eaat9773. doi: 10.1126/scisignal.aat9773.

PMID:
30301790
12.

Association between brain atrophy and cognitive motor interference in multiple sclerosis.

Coghe G, Fenu G, Lorefice L, Zucca E, Porta M, Pilloni G, Corona F, Frau J, Giovanna Marrosu M, Pau M, Cocco E.

Mult Scler Relat Disord. 2018 Oct;25:208-211. doi: 10.1016/j.msard.2018.07.045. Epub 2018 Jul 31.

PMID:
30103173
13.

Top-down proteomic profiling of human saliva in multiple sclerosis patients.

Manconi B, Liori B, Cabras T, Vincenzoni F, Iavarone F, Lorefice L, Cocco E, Castagnola M, Messana I, Olianas A.

J Proteomics. 2018 Sep 15;187:212-222. doi: 10.1016/j.jprot.2018.07.019. Epub 2018 Aug 4.

PMID:
30086402
14.

Determinants of therapy switch in multiple sclerosis treatment-naïve patients: A real-life study.

Saccà F, Lanzillo R, Signori A, Maniscalco GT, Signoriello E, Lo Fermo S, Repice A, Annovazzi P, Baroncini D, Clerico M, Binello E, Cerqua R, Mataluni G, Bonavita S, Lavorgna L, Zarbo IR, Laroni A, Rossi S, Pareja Gutierrez L, La Gioia S, Frigeni B, Barcella V, Frau J, Cocco E, Fenu G, Torri Clerici V, Sartori A, Rasia S, Cordioli C, Di Sapio A, Pontecorvo S, Grasso R, Barrilà C, Russo CV, Esposito S, Ippolito D, Bovis F, Gallo F, Sormani MP; ; On behalf of the iMUST Group.

Mult Scler. 2018 Jul 25:1352458518790390. doi: 10.1177/1352458518790390. [Epub ahead of print]

PMID:
30044207
15.

Inhibition of BET Bromodomain Proteins with GS-5829 and GS-626510 in Uterine Serous Carcinoma, a Biologically Aggressive Variant of Endometrial Cancer.

Bonazzoli E, Predolini F, Cocco E, Bellone S, Altwerger G, Menderes G, Zammataro L, Bianchi A, Pettinella F, Riccio F, Han C, Yadav G, Lopez S, Manzano A, Manara P, Buza N, Hui P, Wong S, Litkouhi B, Ratner E, Silasi DA, Huang GS, Azodi M, Schwartz PE, Schlessinger J, Santin AD.

Clin Cancer Res. 2018 Oct 1;24(19):4845-4853. doi: 10.1158/1078-0432.CCR-18-0864. Epub 2018 Jun 25.

PMID:
29941483
16.

Oncogenic TRK fusions are amenable to inhibition in hematologic malignancies.

Taylor J, Pavlick D, Yoshimi A, Marcelus C, Chung SS, Hechtman JF, Benayed R, Cocco E, Durham BH, Bitner L, Inoue D, Chung YR, Mullaney K, Watts JM, Diamond EL, Albacker LA, Mughal TI, Ebata K, Tuch BB, Ku N, Scaltriti M, Roshal M, Arcila M, Ali S, Hyman DM, Park JH, Abdel-Wahab O.

J Clin Invest. 2018 Aug 31;128(9):3819-3825. doi: 10.1172/JCI120787. Epub 2018 Aug 6.

17.

Clinical activity after fingolimod cessation: disease reactivation or rebound?

Frau J, Sormani MP, Signori A, Realmuto S, Baroncini D, Annovazzi P, Signoriello E, Maniscalco GT, La Gioia S, Cordioli C, Frigeni B, Rasia S, Fenu G, Grasso R, Sartori A, Lanzillo R, Stromillo ML, Rossi S, Forci B, Cocco E; i-MuST study group.

Eur J Neurol. 2018 Oct;25(10):1270-1275. doi: 10.1111/ene.13694. Epub 2018 Jul 10.

PMID:
29851435
18.

Does focal inflammation have an impact on cognition in multiple sclerosis? An MRI study.

Fenu G, Arru M, Lorefice L, Frau J, Coghe G, Fronza M, Loi L, Barracciu MA, Marrosu MG, Cocco E.

Mult Scler Relat Disord. 2018 Jul;23:83-87. doi: 10.1016/j.msard.2018.05.012. Epub 2018 May 16.

PMID:
29800885
19.

A cross-sectional and longitudinal study evaluating brain volumes, RNFL, and cognitive functions in MS patients and healthy controls.

Frau J, Fenu G, Signori A, Coghe G, Lorefice L, Barracciu MA, Sechi V, Cabras F, Badas M, Marrosu MG, Cocco E.

BMC Neurol. 2018 May 11;18(1):67. doi: 10.1186/s12883-018-1065-9.

20.

New horizons for multiple sclerosis therapeutics: milestones in the development of ocrelizumab.

Frau J, Coghe G, Lorefice L, Fenu G, Cocco E.

Neuropsychiatr Dis Treat. 2018 Apr 23;14:1093-1099. doi: 10.2147/NDT.S147874. eCollection 2018. Review.

21.

KAT3B-p300 and H3AcK18/H3AcK14 levels are prognostic markers for kidney ccRCC tumor aggressiveness and target of KAT inhibitor CPTH2.

Cocco E, Leo M, Canzonetta C, Di Vito S, Mai A, Rotili D, Di Napoli A, Vecchione A, De Nunzio C, Filetici P, Stoppacciaro A.

Clin Epigenetics. 2018 Apr 4;10:44. doi: 10.1186/s13148-018-0473-4. eCollection 2018.

22.

Pregnancy planning and outcomes in patients with multiple sclerosis after mitoxantrone therapy: a monocentre assessment.

Frau J, Coghe G, Casanova P, Sardu C, Lorefice L, Fenu G, Marrosu MG, Cocco E.

Eur J Neurol. 2018 Aug;25(8):1063-1068. doi: 10.1111/ene.13650. Epub 2018 Apr 25.

PMID:
29611885
23.

Fatigue, as measured using the Modified Fatigue Impact Scale, is a predictor of processing speed improvement induced by exercise in patients with multiple sclerosis: data from a randomized controlled trial.

Coghe G, Corona F, Marongiu E, Fenu G, Frau J, Lorefice L, Crisafulli A, Galli M, Concu A, Marrosu MG, Pau M, Cocco E.

J Neurol. 2018 Jun;265(6):1328-1333. doi: 10.1007/s00415-018-8836-5. Epub 2018 Mar 24.

PMID:
29574556
24.

A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study.

Lanzillo R, Prosperini L, Gasperini C, Moccia M, Fantozzi R, Tortorella C, Nociti V, Annovazzi P, Cavalla P, Radaelli M, Malucchi S, Clerici VT, Boffa L, Buttari F, Ragonese P, Maniscalco GT, Di Filippo M, Buscarinu MC, Pinardi F, Gallo A, Coghe G, Pesci I, Laroni A, Gajofatto A, Calabrese M, Tomassini V, Cocco E, Solaro C; R.I.Re.MS study group.

J Neurol. 2018 May;265(5):1174-1183. doi: 10.1007/s00415-018-8831-x. Epub 2018 Mar 16.

PMID:
29549468
25.

Adult brain volume in multiple sclerosis: The impact of paediatric onset.

Fenu G, Lorefice L, Loi L, Sechi V, Contu F, Coghe G, Frau J, Spinicci G, Barracciu MA, Marrosu MG, Cocco E.

Mult Scler Relat Disord. 2018 Apr;21:103-107. doi: 10.1016/j.msard.2018.03.004. Epub 2018 Mar 6.

PMID:
29544192
26.

Autoimmune comorbidities in multiple sclerosis: what is the influence on brain volumes? A case-control MRI study.

Lorefice L, Fenu G, Pitzalis R, Scalas G, Frau J, Coghe G, Musu L, Sechi V, Barracciu MA, Marrosu MG, Cocco E.

J Neurol. 2018 May;265(5):1096-1101. doi: 10.1007/s00415-018-8811-1. Epub 2018 Mar 5.

PMID:
29508133
27.

Exploring cognitive motor interference in multiple sclerosis by the visual Stroop test.

Coghe G, Pilloni G, Zucca E, Porta M, Corona F, Frau J, Fenu G, Lorefice L, Marrosu MG, Pau M, Cocco E.

Mult Scler Relat Disord. 2018 May;22:8-11. doi: 10.1016/j.msard.2018.02.026. Epub 2018 Feb 24.

PMID:
29501850
28.

Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks.

Portaccio E, Annovazzi P, Ghezzi A, Zaffaroni M, Moiola L, Martinelli V, Lanzillo R, Brescia Morra V, Rinaldi F, Gallo P, Tortorella C, Paolicelli D, Pozzilli C, De Giglio L, Cavalla P, Cocco E, Marrosu MG, Patti F, Solaro C, Bellantonio P, Uccelli A, Laroni A, Pastò L, Giannini M, Trojano M, Comi G, Amato MP; MS Study Group of the Italian Neurological Society.

Neurology. 2018 Mar 6;90(10):e823-e831. doi: 10.1212/WNL.0000000000005067. Epub 2018 Feb 7.

PMID:
29438046
29.

Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks.

Portaccio E, Moiola L, Martinelli V, Annovazzi P, Ghezzi A, Zaffaroni M, Lanzillo R, Brescia Morra V, Rinaldi F, Gallo P, Tortorella C, Paolicelli D, Pozzilli C, De Giglio L, Cavalla P, Cocco E, Marrosu MG, Solaro C, Uccelli A, Laroni A, Pastò L, Giannini M, Trojano M, Comi G, Amato MP; MS Study Group of the Italian Neurological Society.

Neurology. 2018 Mar 6;90(10):e832-e839. doi: 10.1212/WNL.0000000000005068. Epub 2018 Feb 7.

PMID:
29438041
30.

Cognition in multiple sclerosis: Between cognitive reserve and brain volume.

Fenu G, Lorefice L, Arru M, Sechi V, Loi L, Contu F, Cabras F, Coghe G, Frau J, Fronza M, Sbrescia G, Lai V, Boi M, Mallus S, Murru S, Porcu A, Barracciu MA, Marrosu MG, Cocco E.

J Neurol Sci. 2018 Mar 15;386:19-22. doi: 10.1016/j.jns.2018.01.011. Epub 2018 Jan 10.

PMID:
29406960
31.

The impact of visible and invisible symptoms on employment status, work and social functioning in Multiple Sclerosis.

Lorefice L, Fenu G, Frau J, Coghe G, Marrosu MG, Cocco E.

Work. 2018;60(2):263-270. doi: 10.3233/WOR-182682.

PMID:
29400690
32.

Pulse steroid therapy in multiple sclerosis and mood changes: An exploratory prospective study.

Lorefice L, Fenu G, Fois M, Frau J, Coghe G, Marrosu MG, Cocco E.

Mult Scler Relat Disord. 2018 Feb;20:104-108. doi: 10.1016/j.msard.2018.01.012. Epub 2018 Jan 31.

PMID:
29360061
33.

Intrathecal oligoclonal bands synthesis in multiple sclerosis: is it always a prognostic factor?

Frau J, Villar LM, Sardu C, Secci MA, Schirru L, Ferraro D, Coghe G, Lorefice L, Fenu G, Bedin R, Sola P, Marrosu MG, Cocco E.

J Neurol. 2018 Feb;265(2):424-430. doi: 10.1007/s00415-017-8716-4. Epub 2017 Dec 22.

PMID:
29273846
34.

Long-term follow-up more than 10 years after HSCT: a monocentric experience.

Frau J, Carai M, Coghe G, Fenu G, Lorefice L, La Nasa G, Mamusa E, Vacca A, Marrosu MG, Cocco E.

J Neurol. 2018 Feb;265(2):410-416. doi: 10.1007/s00415-017-8718-2. Epub 2017 Dec 21.

PMID:
29270686
35.

Texting while walking differently alters gait patterns in people with multiple sclerosis and healthy individuals.

Pau M, Corona F, Pilloni G, Porta M, Coghe G, Cocco E.

Mult Scler Relat Disord. 2018 Jan;19:129-133. doi: 10.1016/j.msard.2017.11.021. Epub 2017 Dec 2.

PMID:
29216541
36.

PML in a person with multiple sclerosis: Is teriflunomide the felon?

Lorefice L, Fenu G, Gerevini S, Frau J, Coghe G, Barracciu MA, Contu F, Marrosu MG, Cocco E.

Neurology. 2018 Jan 9;90(2):83-85. doi: 10.1212/WNL.0000000000004804. Epub 2017 Dec 6. No abstract available.

PMID:
29212829
37.

Validation of the Arm Profile Score in assessing upper limb functional impairments in people with multiple sclerosis.

Corona F, Gervasoni E, Coghe G, Cocco E, Ferrarin M, Pau M, Cattaneo D.

Clin Biomech (Bristol, Avon). 2018 Jan;51:45-50. doi: 10.1016/j.clinbiomech.2017.11.010. Epub 2017 Nov 22.

PMID:
29179033
38.

Lack of CD4+ T cell percent decrease in alemtuzumab-treated multiple sclerosis patients with persistent relapses.

Rolla S, De Mercanti SF, Bardina V, Horakova D, Habek M, Adamec I, Cocco E, Annovazzi P, Vladic A, Novelli F, Durelli L, Clerico M.

J Neuroimmunol. 2017 Dec 15;313:89-91. doi: 10.1016/j.jneuroim.2017.10.009. Epub 2017 Oct 17.

39.

Do gait patterns differ in men and women with multiple sclerosis?

Pau M, Corona F, Pilloni G, Porta M, Coghe G, Cocco E.

Mult Scler Relat Disord. 2017 Nov;18:202-208. doi: 10.1016/j.msard.2017.10.005. Epub 2017 Oct 9.

PMID:
29141811
40.

Brain volume in early MS patients with and without IgG oligoclonal bands in CSF.

Fenu G, Lorefice L, Sechi V, Loi L, Contu F, Cabras F, Coghe G, Frau J, Secci MA, Melis C, Schirru L, Costa G, Melas V, Arru M, Barracciu MA, Marrosu MG, Cocco E.

Mult Scler Relat Disord. 2018 Jan;19:55-58. doi: 10.1016/j.msard.2017.11.005. Epub 2017 Nov 8.

PMID:
29132035
41.

Multiple sclerosis and HLA genotypes: A possible influence on brain atrophy.

Lorefice L, Fenu G, Sardu C, Frau J, Coghe G, Costa G, Schirru L, Secci MA, Sechi V, Barracciu MA, Marrosu MG, Cocco E.

Mult Scler. 2019 Jan;25(1):23-30. doi: 10.1177/1352458517739989. Epub 2017 Nov 7.

PMID:
29111883
42.

Assessing association of comorbidities with treatment choice and persistence in MS: A real-life multicenter study.

Laroni A, Signori A, Maniscalco GT, Lanzillo R, Russo CV, Binello E, Lo Fermo S, Repice A, Annovazzi P, Bonavita S, Clerico M, Baroncini D, Prosperini L, La Gioia S, Rossi S, Cocco E, Frau J, Torri Clerici V, Signoriello E, Sartori A, Zarbo IR, Rasia S, Cordioli C, Cerqua R, Di Sapio A, Lavorgna L, Pontecorvo S, Barrilà C, Saccà F, Frigeni B, Esposito S, Ippolito D, Gallo F, Sormani MP; iMUST group.

Neurology. 2017 Nov 28;89(22):2222-2229. doi: 10.1212/WNL.0000000000004686. Epub 2017 Nov 1.

PMID:
29093064
43.

Cerebrospinal fluid analysis and the determination of oligoclonal bands.

Gastaldi M, Zardini E, Leante R, Ruggieri M, Costa G, Cocco E, De Luca G, Cataldo I, Biagioli T, Ballerini C, Castellazzi M, Fainardi E, Pettini P, Zaffaroni M, Giunti D, Capello E, Bernardi G, Ciusani E, Giannotta C, Nobile-Orazio E, Bazzigaluppi E, Passerini G, Bedin R, Sola P, Brivio R, Cavaletti G, Sala A, Bertolotto A, Desina G, Leone MA, Mariotto S, Ferrari S, Paternoster A, Giavarina D, Lolli F, Franciotta D.

Neurol Sci. 2017 Oct;38(Suppl 2):217-224. doi: 10.1007/s10072-017-3034-2. Review.

PMID:
29030765
44.

Differential Lipid Composition and Gene Expression in the Semi-Russeted "Cox Orange Pippin" Apple Variety.

Legay S, Cocco E, André CM, Guignard C, Hausman JF, Guerriero G.

Front Plant Sci. 2017 Sep 26;8:1656. doi: 10.3389/fpls.2017.01656. eCollection 2017.

45.

Rescue therapy with alemtuzumab in multiple sclerosis post-natalizumab puerperium reactivation.

Frau J, Coghe G, Fenu G, Lorefice L, Cocco E.

Neurol Sci. 2018 Feb;39(2):389-390. doi: 10.1007/s10072-017-3135-y. Epub 2017 Oct 7. No abstract available.

PMID:
28986705
46.

'Timed up and go' and brain atrophy: a preliminary MRI study to assess functional mobility performance in multiple sclerosis.

Lorefice L, Coghe G, Fenu G, Porta M, Pilloni G, Frau J, Corona F, Sechi V, Barracciu MA, Marrosu MG, Pau M, Cocco E.

J Neurol. 2017 Nov;264(11):2201-2204. doi: 10.1007/s00415-017-8612-y. Epub 2017 Sep 11.

PMID:
28894919
47.

Smoothness of gait detects early alterations of walking in persons with multiple sclerosis without disability.

Pau M, Mandaresu S, Pilloni G, Porta M, Coghe G, Marrosu MG, Cocco E.

Gait Posture. 2017 Oct;58:307-309. doi: 10.1016/j.gaitpost.2017.08.023. Epub 2017 Aug 24.

PMID:
28858779
48.

Localized pigmentation disorder after subcutaneous pegylated interferon beta-1a injection.

Coghe G, Atzori L, Frau J, Fenu G, Lorefice L, Marrosu MG, Cocco E.

Mult Scler. 2018 Feb;24(2):231-233. doi: 10.1177/1352458517708465. Epub 2017 Jul 28.

PMID:
28752785
49.

Metabolomic analysis identifies altered metabolic pathways in Multiple Sclerosis.

Poddighe S, Murgia F, Lorefice L, Liggi S, Cocco E, Marrosu MG, Atzori L.

Int J Biochem Cell Biol. 2017 Dec;93:148-155. doi: 10.1016/j.biocel.2017.07.004. Epub 2017 Jul 16.

PMID:
28720279
50.

The burden of multiple sclerosis and patients' coping strategies.

Lorefice L, Fenu G, Frau J, Coghe G, Marrosu MG, Cocco E.

BMJ Support Palliat Care. 2018 Mar;8(1):38-40. doi: 10.1136/bmjspcare-2017-001324. Epub 2017 Jun 24.

PMID:
28647714

Supplemental Content

Support Center